NO20050060L - Medikament for behandling av overaktiv blaere - Google Patents
Medikament for behandling av overaktiv blaereInfo
- Publication number
- NO20050060L NO20050060L NO20050060A NO20050060A NO20050060L NO 20050060 L NO20050060 L NO 20050060L NO 20050060 A NO20050060 A NO 20050060A NO 20050060 A NO20050060 A NO 20050060A NO 20050060 L NO20050060 L NO 20050060L
- Authority
- NO
- Norway
- Prior art keywords
- medication
- treatment
- overactive bladder
- overactive
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Et terapeutisk middel mot overaktiv urinblære inneholdende tamsulosin eller et farmasøytisk akseptabelt salt derav som en effektiv ingrediens.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002166408 | 2002-06-07 | ||
PCT/JP2003/007149 WO2003103659A1 (ja) | 2002-06-07 | 2003-06-05 | 過活動膀胱治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050060L true NO20050060L (no) | 2005-03-04 |
Family
ID=29727628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050060A NO20050060L (no) | 2002-06-07 | 2005-01-06 | Medikament for behandling av overaktiv blaere |
Country Status (16)
Country | Link |
---|---|
US (2) | US20060035923A1 (no) |
EP (1) | EP1552825A4 (no) |
JP (1) | JP4466370B2 (no) |
KR (1) | KR20050008795A (no) |
CN (1) | CN100355419C (no) |
AR (1) | AR040248A1 (no) |
AU (1) | AU2003242166A1 (no) |
BR (1) | BR0311414A (no) |
CA (1) | CA2487899A1 (no) |
IL (1) | IL165370A0 (no) |
MX (1) | MXPA04012070A (no) |
NO (1) | NO20050060L (no) |
PL (1) | PL372560A1 (no) |
RU (1) | RU2004135563A (no) |
TW (1) | TW200408387A (no) |
WO (1) | WO2003103659A1 (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7442387B2 (en) * | 2003-03-06 | 2008-10-28 | Astellas Pharma Inc. | Pharmaceutical composition for controlled release of active substances and manufacturing method thereof |
US20050175689A1 (en) * | 2003-10-27 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | Coated fine particles containing drug for intrabuccally fast disintegrating tablet |
US8197846B2 (en) * | 2003-11-10 | 2012-06-12 | Astellas Pharma Inc. | Sustained release pharmaceutical composition |
US8039482B2 (en) * | 2004-03-25 | 2011-10-18 | Astellas Pharma Inc. | Composition of solifenacin or salt thereof for use in solid formulation |
CN101601673B (zh) * | 2004-03-25 | 2012-07-18 | 安斯泰来制药株式会社 | 用于固体制剂的索非那新或其盐的组合物 |
ES2387571T3 (es) * | 2004-12-27 | 2012-09-26 | Astellas Pharma Inc. | Composición farmacéutica granulada estable de solifenacina o de su sal |
EP1832288B1 (en) * | 2004-12-27 | 2012-06-20 | Astellas Pharma Inc. | Stable granular pharmaceutical composition of solifenacin or its salt |
US20090131469A1 (en) * | 2005-02-25 | 2009-05-21 | Astellas Pharma Inc. | Pharmaceutical agent comprising solifenacin |
US7815939B2 (en) | 2005-07-20 | 2010-10-19 | Astellas Pharma Inc. | Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms |
WO2009013846A1 (ja) * | 2007-07-20 | 2009-01-29 | Astellas Pharma Inc. | 前立腺肥大に伴う下部尿路症状の改善用医薬組成物 |
DK2216021T3 (da) | 2007-11-02 | 2012-11-05 | Astellas Pharma Inc | Farmaceutisk sammensætning til behandling af overaktiv blære |
JPWO2009081837A1 (ja) * | 2007-12-21 | 2011-05-06 | アステラス製薬株式会社 | 下部尿路症状の改善用医薬組成物 |
EP2181707A1 (en) * | 2008-11-04 | 2010-05-05 | Astellas Ireland Co., Ltd. | Combined use of an alpha-adrenergic receptor antagonist and an anti-muscarinic agent |
US9198904B2 (en) * | 2009-02-04 | 2015-12-01 | Astellas Pharma Inc. | Pharmaceutical composition for oral administration |
US9119878B2 (en) | 2010-07-08 | 2015-09-01 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
KR102027912B1 (ko) * | 2011-02-15 | 2019-10-02 | 지엘팜텍주식회사 | 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제 |
MY174090A (en) * | 2012-03-19 | 2020-03-09 | Wellesley Pharmaceuticals Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
CN102743757A (zh) * | 2012-07-09 | 2012-10-24 | 张家华 | 治疗膀胱流出道梗阻所致膀胱活动过度的药物 |
US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
CN106265667B (zh) * | 2015-05-18 | 2019-01-25 | 中国科学院生物物理研究所 | 一种氯喹的用途 |
CN106562968B (zh) * | 2015-10-13 | 2019-08-13 | 南京华威医药科技集团有限公司 | 包含盐酸坦洛辛和琥珀酸索利那新的药物组合物 |
KR101879133B1 (ko) * | 2017-07-11 | 2018-07-17 | (주)동구바이오제약 | 비뇨기 질환 예방 또는 치료용 제제 및 이의 제조방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391825A (en) * | 1980-02-08 | 1995-02-21 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl substituted phenethylamine intermediates |
NO2005012I1 (no) * | 1994-12-28 | 2005-06-06 | Debio Rech Pharma Sa | Triptorelin og farmasoytisk akseptable salter derav |
US6319920B1 (en) * | 1998-02-27 | 2001-11-20 | Syntex (U.S.A.) Llc | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives |
TW536402B (en) * | 1998-06-26 | 2003-06-11 | Yamanouchi Pharma Co Ltd | Pharmaceutical composition for the therapy of voiding dysfunction |
ID30249A (id) * | 1999-08-09 | 2001-11-15 | Yamanouchi Pharma Co Ltd | Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah |
IL141235A (en) * | 2000-02-09 | 2012-04-30 | Novartis Int Pharm Ltd | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia |
ATE365554T1 (de) * | 2003-04-04 | 2007-07-15 | Dynogen Pharmaceuticals Inc | Methode zur behandlung von erkrankungen der unteren harnwege |
-
2003
- 2003-06-05 WO PCT/JP2003/007149 patent/WO2003103659A1/ja active Application Filing
- 2003-06-05 MX MXPA04012070A patent/MXPA04012070A/es active IP Right Grant
- 2003-06-05 CA CA002487899A patent/CA2487899A1/en not_active Abandoned
- 2003-06-05 PL PL03372560A patent/PL372560A1/xx unknown
- 2003-06-05 JP JP2004510778A patent/JP4466370B2/ja not_active Expired - Lifetime
- 2003-06-05 IL IL16537003A patent/IL165370A0/xx unknown
- 2003-06-05 RU RU2004135563/15A patent/RU2004135563A/ru not_active Application Discontinuation
- 2003-06-05 BR BR0311414-7A patent/BR0311414A/pt not_active IP Right Cessation
- 2003-06-05 AU AU2003242166A patent/AU2003242166A1/en not_active Abandoned
- 2003-06-05 CN CNB038131498A patent/CN100355419C/zh not_active Expired - Fee Related
- 2003-06-05 KR KR10-2004-7019807A patent/KR20050008795A/ko not_active Application Discontinuation
- 2003-06-05 US US10/517,137 patent/US20060035923A1/en not_active Abandoned
- 2003-06-05 EP EP03730850A patent/EP1552825A4/en not_active Withdrawn
- 2003-06-06 TW TW092115435A patent/TW200408387A/zh unknown
- 2003-06-06 AR ARP030102019A patent/AR040248A1/es not_active Application Discontinuation
-
2005
- 2005-01-06 NO NO20050060A patent/NO20050060L/no not_active Application Discontinuation
-
2006
- 2006-12-22 US US11/643,762 patent/US20070270459A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL165370A0 (en) | 2006-01-15 |
AU2003242166A1 (en) | 2003-12-22 |
US20060035923A1 (en) | 2006-02-16 |
PL372560A1 (en) | 2005-07-25 |
RU2004135563A (ru) | 2005-06-10 |
JP4466370B2 (ja) | 2010-05-26 |
EP1552825A1 (en) | 2005-07-13 |
EP1552825A4 (en) | 2009-11-25 |
TW200408387A (en) | 2004-06-01 |
CN100355419C (zh) | 2007-12-19 |
US20070270459A1 (en) | 2007-11-22 |
AR040248A1 (es) | 2005-03-23 |
JPWO2003103659A1 (ja) | 2005-10-06 |
BR0311414A (pt) | 2005-03-15 |
KR20050008795A (ko) | 2005-01-21 |
CN1658859A (zh) | 2005-08-24 |
CA2487899A1 (en) | 2003-12-18 |
WO2003103659A1 (ja) | 2003-12-18 |
MXPA04012070A (es) | 2005-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050060L (no) | Medikament for behandling av overaktiv blaere | |
NO20053042L (no) | Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi. | |
NO20032233L (no) | Synergistiske foreninger som innbefatter en renininhibitor for kardiovaskulaere sykdommer | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
AR044923A1 (es) | Imidazoquinolinas sustituidas con sulfonamida | |
NO20044054L (no) | Administrering av midler for behandling av betennelse | |
DK1689724T3 (da) | Quinazolinonforbindelser som anticancermidler | |
NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
AU2003259381A1 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
AR032293A1 (es) | Estuche farmaceutico | |
MXPA05004697A (es) | Soluciones farmaceuticas que comprenden un compuesto modafinil y uso para la fabricacion de un medicamento para tratar diferentes enfermedades. | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
WO2006064228A3 (en) | Thiazolopyramidine compounds for the modulation of chemokine receptor activity | |
AR028448A1 (es) | Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares | |
NO20054320L (no) | Terapeutisk middel mot hemoroidesykdom | |
NO20023111L (no) | Utvortes preparat for behandling av pruritus | |
NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
NO20054718L (no) | Terapeutisk og/eller preventivt middel for kroniske hudsykdommer | |
AR022348A1 (es) | Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior | |
HRP20050497B1 (en) | Use of levocetirizine for the persistent allergic rhinitis | |
AU2003281257A1 (en) | A novel use of rapamycin and structural analogues thereof | |
NO20050445L (no) | Synergistisk interaksjon mellom abacavir og alovudin | |
NO20042586L (no) | Behandlingsfremgangsmate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |